| Factor Information | |
|---|---|
| Data ID | 380 |
| Factor | Left Thoracotomy on the Prevalence of a High Thoracic Curve |
| Description | The surgical treatment of congenital heart disease is reported to be associated with a high prevalence of scoliosis, although the detailed etiology is unknown. Surgical interventions involving the rib cage are considered to increase the risk of scoliosis. However, whether the cardiac condition or the procedure performed makes patients more susceptible to the development of spinal deformity is controversial. |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | elucidate the prevalence of scoliosis among patients with CHD who underwent cardiac surgery with use of procedures involving the immature rib cage (sternotomy and/or thoracotomy) in the first year of life. |
| p Value | <0.001 |
| Conclusion | Surgery for the treatment of congenital heart disease during the first year of life was associated with a high prevalence of scoliosis (≥40%). While female sex was one of several predictors of ≥10° scoliosis, cardiomegaly was the sole predictor of ≥45° scoliosis. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 445 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/VSD/CoA/ITA/SV/D-TGA/AVSD/TAPVD/DORV/AV block/PDA/ASD/ccTGA/PA, IVS/MS/MR/CAT/AS/AOR/other |
| Reference | |
|---|---|
| PMID | 30229236 |
| Year | 2018 |
| Title | Prevalence of and Predictive Factors for Scoliosis After Surgery for Congenital Heart Disease in the First Year of Life. |
| Sample | ||
|---|---|---|
| Population | CHD patients | |
| Source | Database | |
| Region | Suita,Japan | |
| Method | reviewed | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | immature rib cage (sternotomy and/or thoracotomy) | |
| Group | thrombosis patients (left thoracotomy)(Treatment) | no thrombosis patients(Control) |
| Number | 32(total:79) | 71(total:331) |
| Age | 14.4 ± 2.9 (10-21) years | 14.4 ± 2.9 (10-21) years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.405 | 0.21 |
